Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Queensland Health
Boehringer Ingelheim
Harvard Business School

Generated: February 21, 2019

DrugPatentWatch Database Preview

Drug Price Trends for OSCIMIN

« Back to Dashboard

Drug Price Trends for OSCIMIN

Average Pharmacy Cost for OSCIMIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
OSCIMIN 0.125 MG TABLET 68047-0252-01 0.18254 EACH 2019-01-23
OSCIMIN SL 0.125 MG TABLET 68047-0253-01 0.17078 EACH 2019-01-23
OSCIMIN 0.125 MG ODT 68047-0254-01 0.20050 EACH 2019-01-23
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.